Theratechnologies Inc (FRA:TQ80)
€ 1.03 -0.02 (-1.9%) Market Cap: 52.33 Mil Enterprise Value: 69.87 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 65/100

Theratechnologies Inc to Present New Development Strategy for Tesamorelin Conference Call Transcript

Jun 17, 2019 / 12:30PM GMT
Release Date Price: €20.1 (+5.79%)
Operator

Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Theratechnologies' Conference Call. (Operator Instructions) I would like to remind everyone that this conference call is being recorded today, June 17, 2019, at 8:30 a.m. Eastern Time.

And I would now like to turn the conference over to Mr. Denis Boucher, Vice President Communications and Corporate Affairs. Mr. Boucher, please go ahead, sir.

Denis Boucher
Theratechnologies Inc. - VP of Communications & Corporate Affairs

Well, good morning. Before we start the conference call, I've been asked to read the following forward-looking information. The following presentation contains statements that are considered forward-looking information within the meaning of securities regulation. The forward-looking information in this presentation relate to future events or our future performance. The forward-looking information are based on a number of assumptions and are associated with a number of risks, uncertainties and other unknown factors that may cause our actual results,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot